DrFirst Rises to ‘Very High’ Rating in 2nd Year on TIME World’s Top HealthTech Companies List
Recognition reflects company momentum in helping providers overcome medication access barriers, including technology
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.

![]()
Recognition reflects company momentum in helping providers overcome medication access barriers, including technology that cuts PA submission time to 49 seconds
ARLINGTON, VA, UNITED STATES, October 23, 2026 /EINPresswire.com/ — DrFirst, a leading healthcare technology pioneer, has been named by TIME to the World’s Top HealthTech Companies list for the second consecutive year, earning recognition in the Health Information & Management category.
DrFirst advanced from a “High” rating in 2025 to “Very High” in 2026, reflecting the company’s continued momentum in helping healthcare organizations improve medication management and reduce barriers to medication access. Presented by TIME and Statista, the World’s Top HealthTech Companies list recognizes 500 companies worldwide, with organizations evaluated on financial performance, reputation analysis and online engagement.
“Too many patients still wait days or weeks to start a medication their doctor has prescribed,” said Laizer Kornwasser, CEO of DrFirst. “Our team has made real progress toward solving that problem, and I’m proud to see that reflected in TIME’s recognition for a second year.”
The distinction comes as DrFirst continues to expand its intelligent medication management capabilities across the patient journey. Over the past year, the company has applied automation to persistent challenges such as prior authorization (PA) and patient engagement:
• A new electronic prior authorization (ePA) solution uses clinical-grade AI to answer PA questions with patient data already captured in the prescribing workflow. In a one-month pilot conducted in mid-2026, the DrFirst solution auto-answered 63% of PBM question sets without clinician edits on more than 2 million questions across 150,000 PAs, with a median time of 49 seconds from open to submission after clinician review.*
• A prescription engagement solution automatically sends a text message from the provider to the patient about a new medication. Healthcare organizations have seen up to 88% patient engagement and a 98% patient satisfaction rating.**
Together, these solutions and others by DrFirst reduce administrative burden for providers while helping patients start and stay on the therapies they need.
About DrFirst
For 25 years, healthcare IT pioneer DrFirst has empowered providers and patients to achieve better health through intelligent medication management. The company has won over 25 awards for excellence and innovation, recognizing the company’s medication management solutions and integrated workflows that make every step of the patient journey easier, from first prescription to ongoing adherence. DrFirst solutions help over 100 million patients a year and are used by more than 670,000 providers, 71,000 pharmacies, 270 EHRs, and 2,000 hospitals in the U.S. To learn more, visit DrFirst.com.
About Statista
Statista publishes hundreds of worldwide industry rankings and company listings with high-profile media partners. This research and analysis service is based on the success of statista.com, the leading data and business intelligence portal that provides statistics, relevant business data, and various market and consumer studies and surveys.
*Based on DrFirst analysis of more than 150,000 pharmacy prior authorizations processed during a one-month study in mid-2026.
**Based on DrFirst analysis of customer results, 2026.
Erin Jundef
Bospar
DrFirst@bospar.com
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
![]()
Media gallery
